ResearcherHerlev HospitalActive in the last 2 years
Bojan Kovacevic
Matched on ORCID iD 0000-0003-3941-0544; OpenAlex author ID A5101660677. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 trial
Papers 4
- Progression of resectable pancreatic ductal adenocarcinoma during surgical delay and effects on survival - A propensity score matched study. Co-author DOI 10.1016/j.pan.2024.11.015↗
- Preoperative EUS-guided biopsy does not affect survival in patients with pancreatic cancer: A nationwide cohort study. Co-author DOI 10.1097/eus.0000000000000156↗
- EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systematic review and meta-analysis. Co-author DOI 10.1016/j.gie.2024.04.012↗
- Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. First author DOI 10.3390/cancers15143677↗
Trials 1
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carsten Palnæs Hansen · 3 shared papers, 2023–2025 · strength 0.73
- Paper Progression of resectable pancreatic ductal adenocarcinoma during surgical delay and effects on survival - A propensity… DOI 10.1016/j.pan.2024.11.015↗
- Paper Preoperative EUS-guided biopsy does not affect survival in patients with pancreatic cancer: A nationwide cohort study. DOI 10.1097/eus.0000000000000156↗
- Paper Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. DOI 10.3390/cancers15143677↗
- Peter Vilmann · 3 shared papers, 2023–2025 · strength 0.66
- Paper EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systemati… DOI 10.1016/j.gie.2024.04.012↗
- Paper Preoperative EUS-guided biopsy does not affect survival in patients with pancreatic cancer: A nationwide cohort study. DOI 10.1097/eus.0000000000000156↗
- Paper Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. DOI 10.3390/cancers15143677↗
- Simon Ezban Grützmeier · 2 shared papers, 2023–2024 · strength 0.41
- Paper EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systemati… DOI 10.1016/j.gie.2024.04.012↗
- Paper Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. DOI 10.3390/cancers15143677↗
- Pia Helene Klausen · 2 shared papers, 2023–2024 · strength 0.41
- Paper EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systemati… DOI 10.1016/j.gie.2024.04.012↗
- Paper Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. DOI 10.3390/cancers15143677↗
- Caroline Ewertsen · 1 shared paper, 2025 · strength 0.33
- Frank Viborg Mortensen · 1 shared paper, 2025 · strength 0.26
- Claus Wilki Fristrup · 1 shared paper, 2025 · strength 0.26
- Mogens Tornby Stender · 1 shared paper, 2025 · strength 0.26
- Jakob Kirkegård · 1 shared paper, 2025 · strength 0.26
- Michael Bau Mortensen · 1 shared paper, 2025 · strength 0.26
- Sönke Detlefsen · 1 shared paper, 2025 · strength 0.26
- Hanne Grossjohann · 1 shared paper, 2023 · strength 0.15
- Estrid Vilma Solyom Høgdall · 1 shared paper, 2023 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.